The 26 conditions recommended by a group consisting of psychiatrists and general practitioners (GPs) is given in [Box 1](#b1){ref-type="boxed-text"}, together with the corresponding F (or Z) number for the main classification (Ustun *et al*, [@r4]; WHO, [@r6]):

**Box 1** The 26 conditions included in ICD10--PHC

  ------- ------------------------------------------------------------------
  F00     Dementia
  F05     Delirium
  F10     Alcohol use disorder
  F11     Drug use disorder
  F17.1   Tobacco use disorder
  F20     Chronic psychosis
  F23     Acute psychosis
  F31     Bipolar disorder
  F32     Depression
  F40     Phobic disorders[^\*^](#t1n1){ref-type="table-fn"}
  F41     Panic disorder
  F41.1   Generalised anxiety
  F42.2   Mixed anxiety and depression[^\*^](#t1n1){ref-type="table-fn"}
  F43     Adjustment disorder[^\*^](#t1n1){ref-type="table-fn"}
  F44     Dissociative disorder
  F45     Unexplained somatic complaints[^\*^](#t1n1){ref-type="table-fn"}
  F48     Neurasthenia[^\*^](#t1n1){ref-type="table-fn"}
  F50     Eating disorders
  F51     Sleep problems
  F52     Sexual disorders (male and female)
  F70     Mental retardation
  F90     Hyperkinetic disorder
  F91     Conduct disorders
  F98     Enuresis
  Z63     Bereavement[^\*^](#t1n1){ref-type="table-fn"}
  ------- ------------------------------------------------------------------

Not to be included in ICD11--PHC.

Experience with the ICD10--PHC {#s1}
==============================

A study by Upton *et al* ([@r3]) with established GPs showed that the guidelines had no impact on the overall detection of mental disorders, the accuracy of diagnosis or the prescription of antidepressants, but there was a significant increase in the number of patients diagnosed with depression or unexplained somatic symptoms, and the GPs also made increased use of psychological interventions. A well-conducted randomised controlled tiral by Croudace *et al* ([@r1]) with established GPs similarly failed to show that the guidelines had any impact either on detection or on patient outcomes. However, the ICD10--PHC has had a major impact in low- and middle-income countries, and is used in the training of nurses and multi-purpose health workers, as well as medical officers (Jenkins *et al*, [@r2]).

However, some of the ICD10--PHC disorders were equivalent to existing categories in the parent classification, and did not take into account developments in diagnostic thinking. An interesting example of this concerns 'medically unexplained symptoms', which appear to have fallen out of favour with our GP colleagues, who have taken the view that even some medically explained symptoms can be abnormally prolonged and accentuated. Psychiatrists have taken a similar view: the new concept of 'complex somatic symptom disorder' being field tested for DSM--V also draws attention not to whether somatic symptoms can be *explained*, but to the cognitive components that may accompany them, whether they are part of a known physical disease or not.

'Mixed anxiety depression disorder' (MADD) was introduced in ICD--10 in order to take account of the fact that patients may just miss the diagnostic threshold for either generalised anxiety or depressive episode, but if they have symptoms of both disorders they are often distressed and disabled by them. However, it is an unsatisfactory concept because there is an unbroken continuum between such 'subthreshold' patients and others who are above the threshold for both, and are at present (confusingly) described as being 'comorbid' for two quite separate disorders. This is because mood disorders and anxiety disorders are in two different chapters of the parent ICD. A revised classification needs to take account of these patients with a combination of symptoms, who give the most common presentation of psychological distress in general medical practice, as well as often being severely disabled by their symptoms.

A fresh look at the problem {#s2}
===========================

The ICD11--PHC is currently under development; the process is advised by a group consisting of approximately equal numbers from high-income, and low- and middle-income countries, of primary care physicians and psychiatrists who actually teach mental health skills to trainees in primary care, and of men and women. The deputy chairman is Dr Michael Klinkman, a GP who represents WONCA (the World Organization of National Colleges, Academies and Academic Associations of General Practitioners/Family Physicians), and another member, Dr Marianne Rosendal, is the European representative on WONCA where classification is concerned.

In our early discussions, many of the disorders in ICD10--PHC are recommended to be retained -- often with suitable amendments -- but there have been several interesting new disorders suggested, as well as several disorders proposed for removal. Perhaps the most radical proposal is to abandon the distinction between anxiety disorders and mood disorders, and to gather them all under the single umbrella of 'dysphoric disorders'. Within this important group, two innovations are proposed. First, some simple operational criteria will be tested in field trials to assess whether clinicians in the field find them useful; if they do not, we could return to diagnosis by descriptions of clinical prototypes. Even if they do like the operational criteria, we will need to recalibrate the point on the scale equivalent to what was previously described as MADD. The simple scales will allow a clinician to diagnose depression and anxiety on their own, or the combination of both -- to be called 'anxious depression'. Second, where any of these three disorders achieve the severity required for a 'case', any somatic symptoms not part of a known physical disorder will be assumed to be related to the dysphoric disorder. Those whose symptoms fall short of the requirements for any of these three diagnoses, but who are distressed and disabled by their current symptoms (whether dysphoric or somatic), are to be given the residual diagnosis of 'distress disorder'. Distress disorder replaces a motley collection of minor disorders, including neurasthenia (or chronic fatigue) and adjustment disorder.

The concept of anxiety disorder will not be exactly equivalent to generalised anxiety disorder (GAD), which by definition has to last at least 6 months. Clinicians in general medical practice need to know what is wrong with the patient now, rather than forming a lifetime concept of the patient's psychological health. Current anxiety is very much more common than GAD, and needs to be recognised if the patient is to receive appropriate reassurance and support.

A new category called bodily distress disorders will include conversion disorder (fairly common in some lower-income countries), health preoccupation (a new disorder similar to hypochondriasis) and the less severe 'bodily distress syndrome'. In the syndrome, the patient is both distressed and concerned and has three or more somatic symptoms in one bodily system. This is diagnosed only if the patient does not have one of the three dysphoric disorders.

Post-traumatic stress disorder and panic/agoraphobia are other new adult disorders. In addition, the GPs on the group wish to have a single category of personality disorder, equivalent to borderline personality. These patients are well known to GPs, and we will try the concept out in a field trial.

Bereavement has been deemed to be surplus to requirements because it is not the only transition that is followed by a psychological disturbance.

Tobacco use disorder has been retained because of its public health importance, and the fact that patients may ask GPs for advice on how to reduce their use of tobacco.

Two new childhood disorders are autism spectrum and specific learning disabilities, as it is thought important that GPs recognise them. They are part of the list of childhood disorders being drawn up by the Childhood Disorders Group at the WHO, and they will be field tested with all the other categories to see whether GPs recognise them and find them useful. The 28 disorders to be field tested have been arranged in eight rough groups, shown as [Box 2](#b2){ref-type="boxed-text"}.

**Box 2** The 28 disorders to be field tested for ICD11--PHC

Childhood disorders

1.  Intellectual development disorder (was mental retardation)

2.  Autism spectrum disorder (new)

3.  Specific learning disability (new)

4.  Attention-deficit hyperactivity disorder (ADHD)

5.  Conduct disorder

6.  Enuresis, encopresis

Psychotic disorders

1.  7 Acute psychosis

2.  8 Chronic psychosis

3.  9 Bipolar disorder

Dysphoric disorders

1.  10 Anxious depression (new)

2.  11 Depressive disorder

3.  12 Anxiety disorder

4.  13 Distress disorder (replaces F42.2, F43, F48)

5.  14 Post-traumatic stress disorder (PTSD) (new)

6.  15 Panic/agoraphobia (was panic disorder)

Body distress disorders

1.  16 Bodily distress syndrome (new -- was unexplained somatic complaints)

2.  17 Health preoccupation (new)

3.  18 Conversion disorder (was dissociative disorder)

Bodily function disorders

1.  19 Sexual function disorder, male

2.  20 Sexual function disorder, female

3.  21 Sleep disorder

4.  22 Eating disorder

Substance use disorders

1.  23 Alcohol use disorders

2.  24 Drug use disorders

3.  25 Tobacco use disorders

Personality disorder

1.  26 Borderline personality (new)

Acquired neurocognitive disorders

1.  27 Dementia

2.  28 Delirium

These proposals are radical indeed, and by no means all of the proposed disorders will survive the field tests. Each proposed category will be commented upon by experts who are not part of the group, as well as by the main advisory group responsible for ICD--11. Final amendments will be made by the primary care group before the revised classification is released for field tests. The field tests are likely to be quite extensive, and to involve studies in both high-income and low- and middle-income countries. A second set of revisions will be made after the field tests. Disorders that survive the field tests must have an equivalent disorder in the main classification -- a requirement which may cause a problem with the new concept of anxious depression, since it requires some modification to the meta-structure of diagnoses used in the main classification.

The field tests will at first be confined to the diagnostic classification to be used in primary care; discussion about optimal management has been deferred to a later stage, but is likely to use the forms of management recommended by the mhGAP study (WHO, [@r7]), with possible additional headings.
